Issue link: http://life-technologies.uberflip.com/i/460858
5 A history of innovation In 1962, Leonard Hayflick made the important discovery that there is a finite capacity for normal human cells to replicate in culture. This finding overturned a long-held belief about the potential immortality of cultured cells and has had far-reaching implications in life science research. That same year, Bob and Earline Ferguson, two biologists working from their garage in Grand Island, New York, recognized the business potential of supplying animal sera for research use. From this humble beginning, Grand Island Biological Company (Gibco ® ) has risen to the forefront of companies supporting global life science research, and is now an important part of Thermo Fisher Scientific. How did the Gibco ® brand become the world leader for sera, media, and reagents? Our company understood then, and still does, that the key to success is consistent delivery of quality products that reduce the number of unknowns scientists may experience in their work. Throughout the global life sciences community, Gibco ® products have a reputation for reliability— allowing scientists to focus on more important things than troubleshooting cell culture problems. In addition to supporting leading-edge life science research, Thermo Fisher Scientific is a leading supplier to the global biopharmaceutical industry. Part of our success is due to our strong commitment to both small and large laboratories, ranging from the research bench to production-scale facilities. The original Gibco ® manufacturing site located in Grand Island, New York, is now just one of many manufacturing facilities worldwide that make Gibco ® cell culture products. Through our unwavering commitment to quality, we continue to provide scientists with the consistent reliability, service, value, and innovation that have made Gibco ® products a global market leader for over 50 years. Gibco ® sera— unassailable quality *